These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Combination of modalities of blood purification therapy for various diseases]. Suzuki T; Ota K Nihon Rinsho; 1991 Dec; 49 Suppl():655-62. PubMed ID: 1808332 [No Abstract] [Full Text] [Related]
4. Prolonged hemoperfusion and hemodialysis in management of hepatic failure and hepatorenal syndrome. Krumlovsky FA; del Greco F; Niederman M Trans Am Soc Artif Intern Organs; 1978; 24():235-8. PubMed ID: 716004 [No Abstract] [Full Text] [Related]
5. [Extracorporeal immunosorption: the prospects for its clinical use]. Mavraev DE; Kazanbiev DN Ter Arkh; 1984; 56(10):74-7. PubMed ID: 6395422 [No Abstract] [Full Text] [Related]
6. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists. Chang TM Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657 [TBL] [Abstract][Full Text] [Related]
7. [Direct hemoperfusion combined with other blood purification]. Negi S; Abe T Nihon Rinsho; 1991 Dec; 49 Suppl():644-8. PubMed ID: 1808330 [No Abstract] [Full Text] [Related]
8. [Effect of hemosorption on the blood levels of certain hormones in patients with pancreonecrosis and the hepatorenal syndrome]. Riabov GA; Pospelov VV; Semenov VN; Bunin VM; Emtsov IuG Anesteziol Reanimatol; 1982; (3):35-7. PubMed ID: 7114564 [No Abstract] [Full Text] [Related]
9. [Therapeutic use of hemoperfusion in internal medicine]. Horký J; Horák J; Filip K Cas Lek Cesk; 1987 Feb; 126(8):225-31. PubMed ID: 3815476 [No Abstract] [Full Text] [Related]
10. Artificial cells in hemoperfusion and other applications. Chang TM Nephron; 1984; 36(3):161-8. PubMed ID: 6366599 [TBL] [Abstract][Full Text] [Related]
11. Improved hemoperfusion systems for renal-hepatic support. Nosé Y; Malchesky PS; Castino F; Koshino I; Scheucher K; Nokoff R Kidney Int Suppl; 1976 Dec; (7):S244-7. PubMed ID: 1070539 [No Abstract] [Full Text] [Related]
12. [Therapeutic plasma exchange: indications and results]. Roujeau JC; Quaranta JF; Guillevin L; Cassuto JP; Chalopin JM; Gajdos P; Sobel A; Rifle G Ann Med Interne (Paris); 1984; 135(4):308-27. PubMed ID: 6236729 [No Abstract] [Full Text] [Related]
13. Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure. Chang TM Kidney Int Suppl; 1976 Dec; (7):S305-11. PubMed ID: 1070552 [No Abstract] [Full Text] [Related]
14. [Combination therapy of plasmapheresis and other blood purification therapy]. Naganuma S; Agishi T Nihon Rinsho; 1991 Dec; 49 Suppl():625-31. PubMed ID: 1808327 [No Abstract] [Full Text] [Related]
15. [Hemosorption in clinical practice (review of the literature)]. Ananchenko VG; Griaznova NA; Glukhovskaia NIa; Kravets TA; Gulevich NV Sov Med; 1981; (2):72-7. PubMed ID: 7017955 [No Abstract] [Full Text] [Related]
16. [Role of the new hemosorbent SUMS-1 in combined intensive therapy of critical states in children]. Rovina AK; Shmakov AI; Rachkovskaia LN; Kokhno VN; Droshnev AI Anesteziol Reanimatol; 1987; (5):45-6. PubMed ID: 3434872 [No Abstract] [Full Text] [Related]